PRO guidance aims to better the capture of `real-world' safety data Guideline 16 November 2013 Pages: 2 - 2
Breakthrough pricing deal between UK Government and big pharma News item 16 November 2013 Pages: 2 - 2
Adherence to AF antiarrhythmic guidelines could be improved Clinical study 16 November 2013 Pages: 3 - 3
Cost of T2DM in Saudi Arabia increases with higher HbA1c Clinical study 16 November 2013 Pages: 3 - 3
Injectable heroin for opiate misusers: is it CE (or even PC)? Clinical study 16 November 2013 Pages: 4 - 4
Aspirin prophylaxis dominates for AVG patency in haemodialysis Clinical study 16 November 2013 Pages: 5 - 5
Integrating family planning and HIV care feasible in Kenya Clinical study 16 November 2013 Pages: 6 - 6
Early specialist care provides better outcomes, reduces costs Clinical study 16 November 2013 Pages: 6 - 6
Do patients' views on antibiotics influence prescribing? Clinical study 16 November 2013 Pages: 7 - 7
Deprivation leads to increased antibiotic use in Scotland Clinical study 16 November 2013 Pages: 7 - 7
Poor HPV vaccine uptake in adolescent girls in Hong Kong Clinical study 16 November 2013 Pages: 8 - 8
Finding ways to support parents' decisions for MMR vaccination Non-clinical study 16 November 2013 Pages: 8 - 8
Primary-care training for knee injections cost effective Clinical study 16 November 2013 Pages: 9 - 9
QOL of an online community of organ-transplant recipients Non-clinical study 16 November 2013 Pages: 9 - 9
High costs may limit uptake of some HER2-targeted treatments Media release 16 November 2013 Pages: 10 - 10
Most oncologists using biosimilars within 12 months of launch Media release 16 November 2013 Pages: 11 - 11
NICE recommends ranibizumab for choroidal neovascularisation . . . News item 16 November 2013 Pages: 11 - 11